2013
DOI: 10.1016/j.freeradbiomed.2013.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Redox signaling in cardiovascular health and disease

Abstract: Spatiotemporal regulation of the activity of a vast array of intracellular proteins and signaling pathways by reactive oxygen species (ROS) governs normal cardiovascular function. However, data from experimental and animal studies strongly support that dysregulated redox signaling, resulting from hyper-activation of various cellular oxidases or mitochondrial dysfunction, is integral to the pathogenesis and progression of cardiovascular disease (CVD). In this review, we address how redox signaling modulates the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
145
0
7

Year Published

2014
2014
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 183 publications
(154 citation statements)
references
References 563 publications
(600 reference statements)
2
145
0
7
Order By: Relevance
“…However, although antioxidants, such as co‐enzyme Q10, N‐acetylcysteine and vitamins C and E, have been reported to exert cardioprotective effects in experimental models (Sterba et al, 2013), the results of small randomized clinical trials have not shown clear benefit (van Dalen et al, 2011; Vincent et al, 2013). The lack of success of antioxidant therapeutic strategies is likely to demonstrate the complexity of redox reactions in biological tissues (Madamanchi and Runge, 2013), in which ROS are known to serve both physiological and maladaptive roles. It is likely, therefore, that selective targeting of particular sources of ROS or downstream effectors may represent a more viable approach.…”
Section: Introductionmentioning
confidence: 99%
“…However, although antioxidants, such as co‐enzyme Q10, N‐acetylcysteine and vitamins C and E, have been reported to exert cardioprotective effects in experimental models (Sterba et al, 2013), the results of small randomized clinical trials have not shown clear benefit (van Dalen et al, 2011; Vincent et al, 2013). The lack of success of antioxidant therapeutic strategies is likely to demonstrate the complexity of redox reactions in biological tissues (Madamanchi and Runge, 2013), in which ROS are known to serve both physiological and maladaptive roles. It is likely, therefore, that selective targeting of particular sources of ROS or downstream effectors may represent a more viable approach.…”
Section: Introductionmentioning
confidence: 99%
“…Some factors are highly associated with heart failure in aging, such as oxidative stress and inflammation (Madamanchi and Runge 2013). Oxidative stress is due to metabolic function degradation causing reactive oxygen species (ROS) accumulation (Ahmed and Tang 2012).…”
Section: Introductionmentioning
confidence: 99%
“…However, ROS overproduction can further promote the inflammatory process and injure neighboring host cells and tissues by lipoperoxidation, proteolysis or DNA degradation (Braga et al, 2012;Mata-Campuzano et al, 2012;Tsumbu et al, 2011). Growing evidence suggests that an abnormal ROS production attributed to an absent regulation of PMNs respiratory burst is involved in the pathogenesis of various inflammatory disorders such as rheumatoid arthritis (Mirshafiey & Mohsenzadegan, 2008;Shah et al, 2011), atherosclerosis (Cheng et al, 2013;Ding et al, 2013), reperfusion injury (Gutowski & Kowalczyk, 2013;Madamanchi & Runge, 2013), and even cancer (Li et al, 2012). Thus, it is interesting to find antioxidative substances with the ability to inhibit ROS production and/or directly scavenge ROS formed in the process of respiratory burst.…”
Section: Introductionmentioning
confidence: 99%